Arthur M Krieg - Net Worth and Insider Trading

Arthur M Krieg Net Worth

The estimated net worth of Arthur M Krieg is at least $8 Million dollars as of 2024-06-06. Arthur M Krieg is the Chief Scientific Officer of Checkmate Pharmaceuticals Inc and owns about 808,510 shares of Checkmate Pharmaceuticals Inc (CMPI) stock worth over $8 Million. Details can be seen in Arthur M Krieg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arthur M Krieg has not made any transactions after 2021-06-16 and currently still holds the listed stock(s).

Transaction Summary of Arthur M Krieg

To

Arthur M Krieg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arthur M Krieg owns 2 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , and Sarepta Therapeutics Inc (SRPT) .

Click here to see the complete history of Arthur M Krieg’s form 4 insider trades.

Insider Ownership Summary of Arthur M Krieg

Ticker Comapny Transaction Date Type of Owner
CMPI Checkmate Pharmaceuticals Inc 2021-06-16 director & Chief Scientific Officer
SRPT Sarepta Therapeutics Inc 2014-01-13 SVP & Chief Scientific Officer

Arthur M Krieg Latest Holdings Summary

Arthur M Krieg currently owns a total of 1 stock. Arthur M Krieg owns 808,510 shares of Checkmate Pharmaceuticals Inc (CMPI) as of June 16, 2021, with a value of $8 Million.

Latest Holdings of Arthur M Krieg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CMPI Checkmate Pharmaceuticals Inc 2021-06-16 808,510 10.50 8,489,355

Holding Weightings of Arthur M Krieg


Arthur M Krieg Form 4 Trading Tracker

According to the SEC Form 4 filings, Arthur M Krieg has made a total of 9 transactions in Checkmate Pharmaceuticals Inc (CMPI) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Checkmate Pharmaceuticals Inc is the acquisition of 3,578 shares on June 16, 2021, which cost Arthur M Krieg around $22,112.

Insider Trading History of Arthur M Krieg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arthur M Krieg Trading Performance

GuruFocus tracks the stock performance after each of Arthur M Krieg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arthur M Krieg is -31.53%. GuruFocus also compares Arthur M Krieg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Arthur M Krieg within 3 months outperforms 0 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Arthur M Krieg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Arthur M Krieg

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -13.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.02 LIMIT LIMIT LIMIT LIMIT LIMIT

Arthur M Krieg Ownership Network

Ownership Network List of Arthur M Krieg

No Data

Ownership Network Relation of Arthur M Krieg

Insider Network Chart

Arthur M Krieg Owned Company Details

What does Checkmate Pharmaceuticals Inc do?

Who are the key executives at Checkmate Pharmaceuticals Inc?

Arthur M Krieg is the director & Chief Scientific Officer of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .

Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Checkmate Pharmaceuticals Inc Insider Transactions

No Available Data

Arthur M Krieg Mailing Address

Above is the net worth, insider trading, and ownership report for Arthur M Krieg. You might contact Arthur M Krieg via mailing address: C/o Checkmate Pharmaceuticals, Inc., 245 Main Street, 2nd Floor, Cambridge Ma 02142.

Discussions on Arthur M Krieg

No discussions yet.